Prediction of the number of positive axillary lymph nodes according to sentinel lymph node involvement and biological subtypes in patients receiving neoadjuvant chemotherapy

Abstract Background Sentinel lymph node biopsy (SLNB) has replaced axillary lymph node dissection (ALND) for assessing axillary lymph node status in clinically node-negative breast cancer patients. However, the approach to axillary surgery after neoadjuvant treatment is still controversial. In the p...

Descripció completa

Dades bibliogràfiques

Autors principals:	Latif Yilmaz, Tulay Kus, Alper Aytekin, Gokmen Aktas, Evren Uzun, Gokturk Maralcan
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2024-07-01
Col·lecció:	BMC Surgery
Matèries:	Prediction Axillary lymph node dissection Stages Sentinel lymph node biopsy Luminal subtypes Neoadjuvant chemotherapy
Accés en línia:	https://doi.org/10.1186/s12893-024-02500-5
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!